Enliven Therapeutics: A Clean Active-Site TKI Could Redefine CML Sequencing

Enliven Therapeutics is positioned as a late-stage, well-capitalized biotech with $895M cash, funding operations into 2030.
Yahoo Finance

FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Forecast to 2034 - Immunovant Advances FcRn Inhibitor Pipeline with Promising Results and FDA Green Light ...

Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering ...

VISTA Inhibitor Market Insights Report 2026 | Featuring Profiles of Aurigene Discovery Technologies, Curis, Hummingbird Bioscience, Kineta, PharmAbcine

The "Global VISTA Inhibitor Market Opportunities & Clinical Trials Insight 2026" has been added to ResearchAndMarkets.com's offering.Thereport delivers a consolidated view of market drivers, ...